Phibro Animal Health Corporation is recalling 240 units of Phibro Nicarb (nicarbazin) 25% Type A Medicated Article, a veterinary medication used for livestock. The recall was initiated because stability testing at the 12-month mark showed the drug's potency had dropped to 24.2%, which is below the required specification of 24.5% to 26.5%. This decreased strength may lead to reduced effectiveness of the medication in treated animals. If you have this product, you should contact your veterinarian or pharmacist for guidance on how to return the unused medication for a refund.
The medication failed to maintain its required strength over time, meaning animals treated with this specific lot may not receive the full intended dose of nicarbazin, potentially compromising the treatment's success.
Potency failure remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response